First in Human Dose Escalation Study Evaluating the Safety and Immunogenicity of IVT's Shigella-04 Vaccine in Healthy Young Adults
Clinical trial NCT07205926 · RECRUITING
Trial details
- NCT number
- NCT07205926
- Sponsor
- Inventprise Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-09
- Primary completion
- 2026-01-26
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.